Aortic valve replacement: validation of the Toronto Aortic Stenosis Quality of Life Questionnaire
Autor: | Lukas Stastny, Mauro Romano, Flavio Ribichini, Jana Kurucova, Jorge Salgado-Fernandez, Martin Thoenes, Cornelia Deutsch, Bruno García del Blanco, Dominique Himbert, Pierluigi Stefàno, Marina Urena-Alcazar, Derk Frank, Carlo Di Mario, Simon Kennon, Nikolaos Bonaros, Thierry Lefèvre, Jose Joaquin Cuenca Castillo, Peter Bramlage, Rima Styra, Lenka Sykorova, Claudia M. Lüske |
---|---|
Přispěvatelé: | Institut Català de la Salut, [Frank D] Department of Internal Medicine III (Cardiology, Angiology and Critical Care), UKSH University Clinical Center Schleswig‐Holstein, and DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Arnold‐Heller Strasse 3, Kiel, 24105, Germany. [Kennon S] Department of Cardiology, Barts Heart Centre, St. Bartholomew’s Hospital, London, UK. [Bonaros N, Stastny L] Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria. [Romano M, Lefèvre T] Department of Thoracic and Cardiovascular Surgery, Department of Interventional Cardiology, Hôpital Privé Jacques Cartier, Massy, France. [Garcia Del Blanco B] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER CV, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus |
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Aortic valve
Quality of life lcsh:Diseases of the circulatory (Cardiovascular) system Chronic condition medicine.medical_specialty Canada Intraclass correlation medicine.medical_treatment Pacients - Satisfacció 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Aortic valve replacement Valve replacement Surveys and Questionnaires Original Research Articles medicine Humans 030212 general & internal medicine Prospective Studies Original Research Article Prospective cohort study Cardiovascular Diseases::Heart Diseases::Heart Valve Diseases::Aortic Valve Stenosis [DISEASES] ambiente y salud pública::salud pública::medidas epidemiológicas::demografía::estado de salud::calidad de vida [ATENCIÓN DE SALUD] Pròtesis valvulars cardíaques business.industry Questionnaire Aortic stenosis intervenciones quirúrgicas::procedimientos quirúrgicos cardiovasculares::procedimientos quirúrgicos cardíacos::implantación de prótesis valvulares cardíacas::sustitución valvular aórtica con catéter [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS] Reproducibility of Results Aortic Valve Stenosis medicine.disease Europe Stenosis Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Health Status::Quality of Life [HEALTH CARE] enfermedades cardiovasculares::enfermedades cardíacas::enfermedades de las válvulas cardíacas::estenosis de la válvula aórtica [ENFERMEDADES] medicine.anatomical_structure Treatment Outcome lcsh:RC666-701 Aortic Valve Physical therapy Vàlvula aòrtica - Estenosi Surgical Procedures Operative::Cardiovascular Surgical Procedures::Cardiac Surgical Procedures::Heart Valve Prosthesis Implantation::Transcatheter Aortic Valve Replacement [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT] Cardiology and Cardiovascular Medicine business |
Zdroj: | Scientia ESC Heart Failure ESC Heart Failure, Vol 8, Iss 1, Pp 270-279 (2021) |
Popis: | Reemplaçament de la vàlvula aòrtica; Qualitat de vida; Qüestionari Reemplazo de la válvula aórtica; Calidad de vida; Cuestionario Aortic valve replacement; Quality of life; Questionnaire Aims There is no quality of life tool specifically developed for patients with severe aortic stenosis (AS) to assess how this chronic condition and its treatment affect patients. The Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ) has been developed to overcome this gap. The results of the validation of the TASQ in patients undergoing treatment for severe AS are presented. Methods and results Prospective study at 10 centres in Europe and Canada, which enrolled 274 patients with severe symptomatic AS undergoing surgical or transcatheter aortic valve replacement. Mean TASQ score at baseline was 71.2 points and increased to 88.9 three months after aortic valve implantation (P < 0.001). Increases were seen for the emotional impact (32.0 to 39.0; P < 0.001), physical limitations (14.8 to 22.0; P < 0.001), and physical symptoms (8.5 vs. 11.0; P < 0.001) domains. Internal consistency was good/excellent for overall TASQ score (α = 0.891) and for the physical limitation, emotional impact, and social limitation domains (α = 0.815–0.950). Test–retest reliability was excellent or strong for the overall TASQ (intraclass correlation coefficient of 0.883) and for the physical symptoms, physical limitation, emotional impact, and social limitation domains (intraclass correlation coefficient of 0.791–0.895). Responsiveness was medium overall (Cohen's d = 0.637) and medium/large for physical symptoms, emotional impact, and physical limitations (0.661–0.812). Sensitivity to change was significant for physical symptoms, physical limitations (both P < 0.001), emotional impact (P = 0.003), and social limitations (P = 0.038). Conclusions The TASQ is a new, brief, self‐administered, and clinically relevant health‐specific tool to measure changes in quality of life in patients with AS undergoing an intervention. This work was supported by a research grant provided by Edwards Lifesciences (Nyon, Switzerland) to the Institute for Pharmacology and Preventive Medicine (Cloppenburg, Germany). |
Databáze: | OpenAIRE |
Externí odkaz: |